Introduction

I
n the UK, routine vaccination of 12-to 13-year-old girls against Human Papillomavirus (HPV) was introduced in September 2008, with a time-limited catch up campaign for girls 14-18 years. Girls should receive information on cervical cancer, HPV as the viral agent and the protection offered by the vaccine, so that parents and girls can together reach an informed decision about participation. Although many mothers will previously have attended cervical screening they may still have little knowledge about the HPV virus or cervical cancer. 1 Previous studies have suggested that misunderstanding of cervical cancer risk and the purpose of screening can be major barriers to women's participation in the cervical screening programme. 2 The HPV vaccination literature presents an opportunity for mothers to learn more about cervical cancer and may encourage them to attend for screening. A number of studies demonstrated that women who attend for cervical screening are more likely to encourage their daughters' vaccination. [3] [4] [5] [6] The present work addresses the reverse scenario-i.e. whether a daughter's involvement in the HPV vaccination programme stimulates cervical screening attendance of mothers. The aim was to investigate whether under-screened mothers of girls eligible for the HPV vaccination were more likely to return to the cervical screening programme than a comparator group of women without a daughter of vaccination age.
Methods
Setting
Within the UK women are invited for free cervical screening every 3 years from age 25 to 49 years, and every 5 years from 50 to 64 years. 7 A dataset created for a previously described study in the North West of England was utilised and is described in Spencer et al. 4 This comprised 112 451 mother-daughter pairs. It included three distinct cohorts: 
Analysis
Logistic regression models were formulated to formally test for differences between groups of women whilst adjusting for demographics and temporal trends, with the outcome being a woman's return to screening within each given month. Details can be found in the online Supplementary material. Under-screened women (unscreened for 5 years or more, subdivided into lapsed or never screened) were selected at the start of each month, and whether or not they returned to the programme during that month was then determined.
The models included calendar time (to adjust for temporal trend), residence in areas with high proportions of minority ethnic populations, Index of Multiple Deprivation quintile, cohort, year of birth (categorised into 5 year age bands) and time since last screen as covariates. Odds ratios (ORs) and 95% confidence intervals (CI) are presented for being a mother (compared with the comparator women) and for the school year when the HPV vaccine was offered, and the year prior to vaccination (when information on vaccination was often first provided).
Results
Full details of demographic characteristics, screening attendance and return rates can be found in Supplementary tables S1, S2 and S3 in the Supplementary material. Figure 1 shows the monthly return rates for the three cohorts of under-screened women linked to a girl eligible for HPV vaccination alongside the comparator group. A large, but temporary increase in screening returners was seen in 2009, although this was not as apparent in those who had never been screened. Screening return rates were consistently higher in mothers compared with the comparator groups across all time periods but in particular, for those women who had never previously attended for screening over the two 2008/09 and 2009/10 HPV vaccination time periods.
The logistic regression models are provided in Supplementary table S4. The difference in the return to screening rate between mothers of girls eligible for vaccination and the comparator groups gave ORs of 1.04 (95% CI 1.02-1.07) for lapsed and 1.57 (1.48-1.67) for never screened (both P < 0.001). There was a significant additional return in the vaccination year (OR 1.05: 1.00-1.10) and 1.16: 1.02-1.31) in the lapsed and never screened respectively) and for the lapsed mothers a modest effect during the year prior to vaccination (OR = 1.06: 1.01-1.10)). Screening return rates were somewhat higher in areas with high ethnic minority populations (OR 1.05-1.10) but decreased with increasing deprivation (OR most deprived quintile; 0.81: 0.78-0.84).
Discussion
The results showed under-screened women living with a girl eligible for the HPV vaccination to be significantly more likely to return to the cervical screening programme following a period of absence than those women who were not linked to a girl in this age group.
The rate of return to screening significantly increased when the HPV vaccination programme was first introduced in 2008/09. Vaccine introduction may account for the improvement, although it was observed for women both linked to a girl of vaccination age and those not. Another plausible explanation is the publicity brought about by the diagnosis in August 2008 and death in March 2009, of the British reality television star Jade Goody from cervical cancer, a phenomenon that translated into an increased cervical screening uptake that was evident in national datasets. 8 Our results demonstrate that, whether due to HPV vaccination and/or the Jade Goody effect, by July 2009 screening attendance nationally returned to previous levels. Taking these temporal trends into consideration we were still able to demonstrate a small but significant impact of the HPV vaccination programme specific to women who had been exposed to the vaccination programme through their daughters' participation. The screening return rate was significantly higher in both the year of, and the year prior to, vaccination. This was especially evident in the vaccination year for those who had never attended for screening previously. One interpretation of our results is that the local and national literature and media coverage that accompanied HPV vaccination reached, and increased, awareness in an important sub-group of non-attending mothers, including those from ethnic minority backgrounds.
Several studies have described the importance of a mother's screening history on her daughter's HPV vaccination uptake. [3] [4] [5] [6] The present analysis extends these observations and shows for the first time that, stimulated by the vaccine programme, some mothers were prompted to take up a screening offer. The 5% increase in screening returners identified in both the year of, and year prior to, the vaccination programme through the logistic regression model, although small, does indicate the potential for synergy between cervical screening and HPV vaccination programmes. This could be further exploited to effectively promote awareness, knowledge, understanding and ultimately, uptake of both programmes.
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
Mothers whose daughters have been offered the HPV vaccine are more likely to return to cervical screening following a period of absence than women without eligible daughters. Mothers screening return rate was seen to be significantly higher in both the year of and the year prior to the HPV vaccination. Information sent to mothers as part of the HPV vaccination programme has the potential to be used to promote cervical screening attendance.
Introduction
T ype 2 diabetes is an increasing health problem in most countries. 1 Age, sex and genetic factors play key roles for diabetes onset; however, diabetes is a preventable disease and obesity is the major modifiable risk factor in the population. [2] [3] [4] [5] The relationships between obesity and blood glucose or diabetes have been demonstrated both in cross-sectional [6] [7] [8] and prospective studies.
9-12
Body mass index (BMI) is the most practical and commonly used anthropometric measure for general fat. 6, 9, 10 However, the body fat (BF) distribution, especially abdominal obesity has been proposed to be a stronger risk factor for diabetes.
13,14 A recent meta-analysis found that waist/height ratio (WHtR) is a better screening tool for cardiometabolic risk factors compared with waist circumference (WC) and BMI. 15 Other studies suggested that both general fat and abdominal fat are risk factor for diabetes. 7, 11 Prospective data on anthropometry and incidence of self-reported diabetes have been reported in a study from Germany. WC was a better predictor than other measures among men and women; WHtR improved the prediction most for men and WHtR and WC were similar predictors for women.
12 Most studies of obesity and incidence of diabetes have been performed in populations from Europe 9,11,12 or USA. 4, 6 However, cross-sectional analyses from the Obesity in Asia Collaboration, including more than 263 000 individuals from 21 studies, reported stronger relationships for WC and type 2 diabetes than for BMI. 8 The aim of this prospective study was to explore the relationship between different anthropometric measures, i.e., BMI, WC, WHtR, waist-hip ratio (WHR) or percent BF (BF%), and incidence of diabetes in a large population-based cohort study.
Methods
Study population
Malmö Diet and Cancer (MDC) cohort, from the city of Malmö in southern Sweden, was used for the present study. All women born between 1923 and 1950 and men born between 1923 and 1945 living in Malmö city were invited to the MDC study during the period
